Skip to main content
. 2010 Jul 26;28(33):5427–5431. doi: 10.1016/j.vaccine.2010.06.005

Table 1.

Schedule of visits, samples collected and assays performed.

Visita 2 3 4 5 6 7 8 9 10 11 12 13 15 16 17 18 19 20 21 22 23



Day/month after first challenge 0 2 4 7 14 21 28 30 32 35 42 49 51 53 56 63 70 74 6 months 9 months 12 months



BCG challenge X X X
PAXGeneb x x x x x x x x x x x x x x x x x x x x x
Arraysc X X X X X X X X X X X X
CMId X X X X X X X
a

Study visit 14 was omitted.

b

Samples of blood taken into PAXGene tubes, RNA extracted and analysis of content and purity performed for these time points.

c

Analysis of RNA by Illumina microarray performed for these time points.

d

PBMCs separated and in vitro culture for IFNγ secretion in response to antigen stimulation performed for these time points.